Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Multiple Sclerosis: EAE/Animal Models

Thursday 04/15/10
01:15 PM - 02:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
MS and Related Diseases
No CME available
Event Timeline
01:15 PM - 02:30 PM Abstract 001 - Reduction of Microglia Activity in a Model of Multiple Sclerosis by Dipyridamole
01:15 PM - 02:30 PM Abstract 002 - Protective Effect of TLR7-Deficiency in Experimental Autoimmune Encephalomyelitis
01:15 PM - 02:30 PM Abstract 003 - Age-Associated Susceptibility to Central Nervous System Autoimmune Disease Is Associated with Cerebral MHCII Expression by CD19+ B Cells, CD8+DC and Gr-1 Monocytes
01:15 PM - 02:30 PM Abstract 004 - Pharmacological PrP-Silencing Accelerates CNS Autoimmune Disease Via TCR Signaling
01:15 PM - 02:30 PM Abstract 005 - Molecular Imaging in Experimental Autoimmune Encephalomyelitis
Faculty Disclosures
Scott S. Zamvil, MD, PhD, FAAN Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Crystal G. Wheeler No disclosure on file
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Bernhard Hemmer, MD No disclosure on file
No disclosure on file
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
Anne Gocke No disclosure on file
Petra Cravens, PhD No disclosure on file
Wei Hu, MD, PhD No disclosure on file
Jeffrey L. Elliott, MD No disclosure on file
J. Scott Sloka, MD No disclosure on file
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has stock in Quest Diagnostics. Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Amy E. Lovett Racke, PhD No disclosure on file
Luanne Metz, MD The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Oliver Neuhaus, MD No disclosure on file
Thomas Korn No disclosure on file
Stefan Nessler, MD No disclosure on file
Martin Weber, MD Dr. Weber has nothing to disclose.
Marie-Laure Santiago-Raber, PhD No disclosure on file
Sima S. Zein, PhD No disclosure on file
Patrick Vollmar No disclosure on file
Christine Stadelmann-Nessler No disclosure on file
Dorothea A. Buck, MD No disclosure on file
John Dsurney, PhD, ABPP No disclosure on file
Sarah E. Buckingham, MD No disclosure on file
Bridgette J. Billioux, MD Dr. Billioux has nothing to disclose.
Shila Azodi, MD Dr. Azodi has nothing to disclose.